Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC)

NCT01210131 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer (SCLC)

Interventions

DRUG: [18F]HX4

Sponsor

Maastricht Radiation Oncology

Collaborators

[object Object]